Top Growing Medical Universities in USA and Canada: 2025 Edition by BIGR

USA and Canada

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 influential women in oncology

FDA Immunotherapy Approvals: First Half of 2025

FDA Immunotherapy Approvals: First Half of 2025

Joshua Budhu: Multidisciplinary Review in Post-Radiation Brain Metastasis Evaluation

joshua budhu

10 Oncology Experts Join OncoDaily Medical Journal’s Editorial Team

OncoDaily Medical Journal

The 9th CAR-TCR Summit: Advancing the Next Era of Engineered Cell Therapies

9th-CAR-TCR-Summit-Europe-2026-1280x720

Tomislav Mihaljevic: $14.5M Raised for VeloSano to Support Cancer Research at Cleveland Clinic

Cleveland Clinic

The First Official World Cervical Cancer Elimination Day of Action on 17 November - UICC

World Cancer Day

OncoCalendar

Loading Events

« All Events

  • This event has passed.

ESH-EBMT-EHA-IPIG 3rd Translational Research Conference

Nov 15, 2024 • 12:00 AM - Nov 17, 2024 • 12:00 AM
ESH-EBMT-EHA-IPIG 3rd Translational Research Conference

The ESH-EBMT-EHA-IPIG 3rd Translational Research Conference on Bone Marrow Failure and Leukaemia Predisposition Syndromes will be held at Paris, France from November 15-17, 2024.

It will offer valuable insights for both clinical and non-clinical scientists, including M.D.s and Ph.D.s of all levels, who are interested in the biology, pathophysiology, diagnosis, and treatment of bone marrow failure syndromes (BMFS) and predisposition syndromes. The conference will address both acquired and inherited BMFS in adults and children, with a particular focus on emerging principles and innovative treatment strategies.

As is customary for ESH, the event will prioritize accessible interactions between young researchers and established experts, as well as between clinicians and basic scientists. Workshops with experts and poster walks will emphasize key topics and provide opportunities for in-depth discussion. The distinguished faculty will ensure a high standard of clinical, translational, and basic research is maintained throughout the conference.

For Registration Visit Here

Organizer

Venue